Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.12 USD | -2.30% | +11.58% | -36.34% |
13/05 | Truist Securities Trims Price Target on Coherus BioSciences to $7 From $8, Maintains Buy Rating | MT |
09/05 | Transcript : Coherus BioSciences, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.34% | 25Cr | |
+9.42% | 11TCr | |
+11.84% | 10TCr | |
-14.15% | 2.24TCr | |
-1.05% | 2.23TCr | |
-5.29% | 1.91TCr | |
-38.29% | 1.8TCr | |
-4.16% | 1.79TCr | |
+7.99% | 1.43TCr | |
+36.24% | 1.25TCr |
- Stock Market
- Equities
- CHRS Stock
- News Coherus BioSciences, Inc.
- UBS Upgrades Coherus BioSciences to Buy From Neutral, $11 Price Target